[News in asthma therapy. Special consideration of the modern selective   2 -stimulators].
D000605:Amino Alcohols / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy* / Q000628:therapy; D001794:Blood Pressure; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D002245:Carbon Dioxide / Q000097:blood; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D009584:Nitrogen / Q000097:blood; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D012129:Respiratory Function Tests; D013566:Sympathomimetics / Q000627:therapeutic use; D012122:Ventilators, Mechanical; D014797:Vital Capacity
D000605:Amino Alcohols; D001993:Bronchodilator Agents; D013566:Sympathomimetics; D002245:Carbon Dioxide; D000628:Aminophylline; D009921:Metaproterenol; D003907:Dexamethasone; D009584:Nitrogen; D004205:Cromolyn Sodium; D010100:Oxygen
Neues in der Asthmabehandlung. Besondere Berücksichtigung der modernen selektiven   2 -Stimulatoren.